company background image
CRMD

CorMedix NasdaqGM:CRMD Stock Report

Last Price

US$4.12

Market Cap

US$170.0m

7D

-6.4%

1Y

7.0%

Updated

26 Jan, 2023

Data

Company Financials +

CRMD Stock Overview

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally.

CRMD fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

CorMedix Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CorMedix
Historical stock prices
Current Share PriceUS$4.12
52 Week HighUS$8.03
52 Week LowUS$2.65
Beta2.35
1 Month Change7.15%
3 Month Change29.97%
1 Year Change7.01%
3 Year Change-38.42%
5 Year Change79.13%
Change since IPO-72.53%

Recent News & Updates

Recent updates

Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

Jul 16
Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Mar 01
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

Sep 09
Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation

CorMedix Inc.'s (NASDAQ:CRMD) Intrinsic Value Is Potentially 58% Above Its Share Price

Feb 11
CorMedix Inc.'s (NASDAQ:CRMD) Intrinsic Value Is Potentially 58% Above Its Share Price

We're Hopeful That CorMedix (NYSEMKT:CRMD) Will Use Its Cash Wisely

Jan 04
We're Hopeful That CorMedix (NYSEMKT:CRMD) Will Use Its Cash Wisely

Shareholder Returns

CRMDUS PharmaceuticalsUS Market
7D-6.4%-0.04%3.1%
1Y7.0%7.9%-8.5%

Return vs Industry: CRMD matched the US Pharmaceuticals industry which returned 7.9% over the past year.

Return vs Market: CRMD exceeded the US Market which returned -9.4% over the past year.

Price Volatility

Is CRMD's price volatile compared to industry and market?
CRMD volatility
CRMD Average Weekly Movement9.9%
Pharmaceuticals Industry Average Movement11.2%
Market Average Movement7.0%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: CRMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: CRMD's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200630Joe Todiscohttps://www.cormedix.com

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007.

CorMedix Inc. Fundamentals Summary

How do CorMedix's earnings and revenue compare to its market cap?
CRMD fundamental statistics
Market CapUS$169.99m
Earnings (TTM)-US$29.28m
Revenue (TTM)US$92.10k

1,846x

P/S Ratio

-5.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CRMD income statement (TTM)
RevenueUS$92.10k
Cost of RevenueUS$51.34k
Gross ProfitUS$40.77k
Other ExpensesUS$29.32m
Earnings-US$29.28m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.71
Gross Margin44.26%
Net Profit Margin-31,794.56%
Debt/Equity Ratio0%

How did CRMD perform over the long term?

See historical performance and comparison